Janux Therapeutics, Inc. (JANX) Capital expenditures 2020–2025
Janux Therapeutics, Inc. (JANX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.0MFY2025 · since FY2020: $0 → $1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.0M | +190.5% |
| FY2024 | $359,000 | -80.6% |
| FY2023 | $1.9M | -71.3% |
| FY2022 | $6.4M | +334.9% |
| FY2021 | $1.5M | — |
| FY2020 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice